CHEPLAPHARM Arzneimittel GmbH

Publications

This section provides relevant information as well as ongoing and timely updates on the strategic and operative success stories of our steadily growing Company.

support_agent

Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

IR center of information

Financial Reports

02nd June 2022
Investor Call Quarterly Report Q1 2022
31st May 2022
Publication Quarterly Report Q1 2022
10th May 2022
Investor Call Full Financial Year 2021 audited
29th April 2022
Publication Full Financial Year 2021 audited
30th November 2021
Investor Call Quarterly Report Q3 2021
19th November 2021
Publication Quarterly Report Q3 2021
24th August 2021
Investor Call Quarterly Report Q2 2021
20th August 2021
Publication Quarterly Report Q2 2021
Find out how you can benefit

Publications

The latest from CHEPLAPHARM

Press releases

04/01/2021

Changes of Management Board per April

more chevron_right
Press releases

03/01/2021

Changes of CHEPLAPHARM Management Board per March

more chevron_right
Investor Relations

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investors Domain

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investor Relations

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Press releases

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Investors Domain

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right
Press releases

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right

Investor Relations topics

Back to top expand_less